Resolutions of the 3rd Extraordinary General Meeting in 2025
Filed with SSE · · 6 pages · Chinese
Beijing Hotgen Biotech Co. Ltd. on 6ix
Earlier from Beijing Hotgen Biotech
- Announcement on Share Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Reply to Letter of Regulatory Inquiry on Information Disclosure of 2024 Annual Report
- Announcement on Term Change and Election of Board of Directors
- Announcement on Completion of Shareholding Reduction Plan by Shareholder and Results of Share Reduction
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Beijing Hotgen Biotech
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Result of Shareholding Reduction by Shareholders with Over 5% Shares
- Announcement on Shareholding Reduction Plan for Controlling Shareholders
- Announcement on Voluntary Disclosure of the Progress in Phase I Clinical Trial for Innovative Drug SGC001 of the Joint-Stock Company
- 2025 Semi-annual Report
Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.
Follow Beijing Hotgen Biotech